Journey Medical Corporation (NASDAQ:DERM) Q3 2025 Earnings Call Transcript

Journey Medical Corporation (NASDAQ:DERM) Q3 2025 Earnings Call Transcript November 12, 2025

Journey Medical Corporation misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.08.

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical Corporation’s Third Quarter 2025 Financial Results and Corporate Update Conference Call. At this time, all participants will be in a listen-only mode. Participants of this call are...